Skip to content

Clinton tells Boston conference of AIDS threat to world democracy

CD4-guided treatment interruption reduces time on therapy by two-thirds

Counting the cost of late presentation for HIV care

All immigrants to UK may be tested for HIV

Barebacking: not a simple phenemenon, US research shows

Tipranavir enters phase III trials

Think HIV: Routine HIV screening programme captures undiagnosed infections

HIV transmission rate ten times higher during primary infection

Atazanavir and amprenavir both pitching for first line therapy with new resistance data